ClinicalTrials.Veeva

Menu

The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery

M

Mersin University

Status

Completed

Conditions

Hemodynamic Instability
Pain

Treatments

Other: virtual reality

Study type

Interventional

Funder types

Other

Identifiers

NCT05585853
MersinUnii

Details and patient eligibility

About

In this study, between 1 January 2025 - 1 June 2025, who met the inclusion and exclusion criteria, a total of 82 patients who are on the 2nd or 3rd day after the surgery and who are hospitalized in the cardiovascular surgery intensive care clinic will be recruited.

Full description

The patient will be put on virtual reality glasses five minutes before the chest tube is removed. Afterwards, it will continue to be watched while the tube is taken and virtual reality glasses will be watched for another five minutes. Pain level and hemodynamic variables will be checked before, during, and 15 and 30 minutes after virtual reality glasses are watched. The participants in the control group will receive routine treatment and care, and their data will be collected at the same time as those in the study group. Hemodynamic variables will be monitored and recorded on the monitor.

Virtual reality glasses application is a method without any side effects. During the research, any adverse condition (vision problem, nausea, dizziness, etc.) related to the use of virtual glasses will be observed by the researcher. Since virtual reality glasses will be used in another patient after being used on one patient, disinfection will be made in line with the company's recommendations, taking into account the pandemic conditions. Throughout the application, feedback will be received from the patients by the researchers.

Enrollment

82 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Conscious and cooperative,
  • Stable hemodynamic status,
  • Speaks and understands Turkish,
  • Over 18 years old,
  • On the 2nd and 3rd day after open heart surgery,
  • Having chest tube,
  • No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied,
  • No active COVID-19 infection,
  • Patients without any psychiatric diagnosis

Exclusion criteria

  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Not conscious,
  • Not cooperative
  • Unstable hemodynamic status,
  • Speaks and understands Turkish,
  • who are under the age of 18,
  • On the 0th or 1st day after surgery,
  • No chest tube,
  • Has sensitivity or trauma in the area (for the study group) where the virtual reality
  • Active COVID-19 infection,
  • Patients with a psychiatric diagnosis

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

82 participants in 2 patient groups

Virtual Reality application group
Experimental group
Description:
Virtual reality glasses (VR Box Virtual Reality Headset 3D Vr Glasses V2.0 2020 model) compatible with the mobile phone (Lenovo P2a42) with the Android operating system will be worn and the patient will be watched (underwater world, open-air museum tours, beach trips and nature scenes) by patients for an average of 10 minutes during chest tube removal.
Treatment:
Other: virtual reality
Standard of care
No Intervention group
Description:
Only standard care will be given and no application will be made.

Trial contacts and locations

1

Loading...

Central trial contact

Tugba CAM YANIK, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems